Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175

The authors wish to make the following correction to this paper [...]

Saved in:
Bibliographic Details
Published in:Vaccines (Basel) 2023-09, Vol.11 (10), p.1538
Main Authors: Narongkiatikhun, Phoom, Noppakun, Kajohnsak, Chaiwarith, Romanee, Winichakoon, Poramed, Vongsanim, Surachet, Suteeka, Yuttitham, Pongsuwan, Karn, Kusirisin, Prit, Wongsarikan, Nuttanun, Fanhchaksai, Kanda, Khamwan, Chantana, Dankai, Dararat, Ophascharoensuk, Vuddhidej
Format: Article
Language:English
Subjects:
Immunogenicity
n/a
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c2668-49501a9ff89949b87c1a8af75178e50297c3013bd2454f09c6144018f5468fb73
container_end_page
container_issue 10
container_start_page 1538
container_title Vaccines (Basel)
container_volume 11
creator Narongkiatikhun, Phoom
Noppakun, Kajohnsak
Chaiwarith, Romanee
Winichakoon, Poramed
Vongsanim, Surachet
Suteeka, Yuttitham
Pongsuwan, Karn
Kusirisin, Prit
Wongsarikan, Nuttanun
Fanhchaksai, Kanda
Khamwan, Chantana
Dankai, Dararat
Ophascharoensuk, Vuddhidej
description The authors wish to make the following correction to this paper [...]
doi_str_mv 10.3390/vaccines11101538
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_929c6cf426094921a033f21956622f43</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_929c6cf426094921a033f21956622f43</doaj_id><sourcerecordid>2883574811</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2668-49501a9ff89949b87c1a8af75178e50297c3013bd2454f09c6144018f5468fb73</originalsourceid><addsrcrecordid>eNpdkstuEzEUhkcIRKvQPUtLbFgwwZe52N2gMAISqSJIhYjd6MRjJ05n7NSeichL8RC8DW-BcwHRWrJ8ZP_-zq_fTpKXBI8ZE_jtDqQ0VgVCCCY540-SS4rLImWCfX_6X32RXIWwwXEIwnhRPk8uWMlFiam4TH5Xznsle-PsNfoM3tnVnYHe3K0Hi1SPoB2jWdcN1q2UNdL0ewS2QbegVSydRlPXudat3BCOB1PVK_9344s3nUrfOxf6gzS2chYWIH_9PGqr9aSZ_yDIVm6REoGgi90joXONgXYfTCREK8r24RpNLJovg_I7OHiFNsJd2B6c71Qkr53v0W0_NPsxWpyDQRRT9gYREmeZv0ieaWiDujqvo-Tbxw9fq2l6M_80qyY3qaRFwdNM5JiA0JoLkYklLyUBDrrMSclVHjMrJcOELRua5ZnGQhYkyzDhOs8KrpclGyWzE7dxsKm3MQLw-9qBqY8bzq9q8L2RraoFjdelzmiBYy9KADOmKRF5UVCqMxZZ706s7bDsVCNjFB7aB9CHJ9as65Xb1QQXhLDi4Ob1meDd_aBCX3cmSNW2YFV8oppyzvIy41E9Sl49km7c4GPURxXlWZTyqMInlYz5B6_0PzcE14d_WT_-l-wP0NHWhQ</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2882848838</pqid></control><display><type>article</type><title>Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Narongkiatikhun, Phoom ; Noppakun, Kajohnsak ; Chaiwarith, Romanee ; Winichakoon, Poramed ; Vongsanim, Surachet ; Suteeka, Yuttitham ; Pongsuwan, Karn ; Kusirisin, Prit ; Wongsarikan, Nuttanun ; Fanhchaksai, Kanda ; Khamwan, Chantana ; Dankai, Dararat ; Ophascharoensuk, Vuddhidej</creator><creatorcontrib>Narongkiatikhun, Phoom ; Noppakun, Kajohnsak ; Chaiwarith, Romanee ; Winichakoon, Poramed ; Vongsanim, Surachet ; Suteeka, Yuttitham ; Pongsuwan, Karn ; Kusirisin, Prit ; Wongsarikan, Nuttanun ; Fanhchaksai, Kanda ; Khamwan, Chantana ; Dankai, Dararat ; Ophascharoensuk, Vuddhidej</creatorcontrib><description>The authors wish to make the following correction to this paper [...]</description><identifier>ISSN: 2076-393X</identifier><identifier>EISSN: 2076-393X</identifier><identifier>DOI: 10.3390/vaccines11101538</identifier><identifier>PMID: 37897029</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>Immunogenicity ; n/a</subject><ispartof>Vaccines (Basel), 2023-09, Vol.11 (10), p.1538</ispartof><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2668-49501a9ff89949b87c1a8af75178e50297c3013bd2454f09c6144018f5468fb73</cites><orcidid>0000-0002-3885-9377 ; 0000-0002-1569-4581</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2882848838/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2882848838?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Narongkiatikhun, Phoom</creatorcontrib><creatorcontrib>Noppakun, Kajohnsak</creatorcontrib><creatorcontrib>Chaiwarith, Romanee</creatorcontrib><creatorcontrib>Winichakoon, Poramed</creatorcontrib><creatorcontrib>Vongsanim, Surachet</creatorcontrib><creatorcontrib>Suteeka, Yuttitham</creatorcontrib><creatorcontrib>Pongsuwan, Karn</creatorcontrib><creatorcontrib>Kusirisin, Prit</creatorcontrib><creatorcontrib>Wongsarikan, Nuttanun</creatorcontrib><creatorcontrib>Fanhchaksai, Kanda</creatorcontrib><creatorcontrib>Khamwan, Chantana</creatorcontrib><creatorcontrib>Dankai, Dararat</creatorcontrib><creatorcontrib>Ophascharoensuk, Vuddhidej</creatorcontrib><title>Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175</title><title>Vaccines (Basel)</title><description>The authors wish to make the following correction to this paper [...]</description><subject>Immunogenicity</subject><subject>n/a</subject><issn>2076-393X</issn><issn>2076-393X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkstuEzEUhkcIRKvQPUtLbFgwwZe52N2gMAISqSJIhYjd6MRjJ05n7NSeichL8RC8DW-BcwHRWrJ8ZP_-zq_fTpKXBI8ZE_jtDqQ0VgVCCCY540-SS4rLImWCfX_6X32RXIWwwXEIwnhRPk8uWMlFiam4TH5Xznsle-PsNfoM3tnVnYHe3K0Hi1SPoB2jWdcN1q2UNdL0ewS2QbegVSydRlPXudat3BCOB1PVK_9344s3nUrfOxf6gzS2chYWIH_9PGqr9aSZ_yDIVm6REoGgi90joXONgXYfTCREK8r24RpNLJovg_I7OHiFNsJd2B6c71Qkr53v0W0_NPsxWpyDQRRT9gYREmeZv0ieaWiDujqvo-Tbxw9fq2l6M_80qyY3qaRFwdNM5JiA0JoLkYklLyUBDrrMSclVHjMrJcOELRua5ZnGQhYkyzDhOs8KrpclGyWzE7dxsKm3MQLw-9qBqY8bzq9q8L2RraoFjdelzmiBYy9KADOmKRF5UVCqMxZZ706s7bDsVCNjFB7aB9CHJ9as65Xb1QQXhLDi4Ob1meDd_aBCX3cmSNW2YFV8oppyzvIy41E9Sl49km7c4GPURxXlWZTyqMInlYz5B6_0PzcE14d_WT_-l-wP0NHWhQ</recordid><startdate>20230928</startdate><enddate>20230928</enddate><creator>Narongkiatikhun, Phoom</creator><creator>Noppakun, Kajohnsak</creator><creator>Chaiwarith, Romanee</creator><creator>Winichakoon, Poramed</creator><creator>Vongsanim, Surachet</creator><creator>Suteeka, Yuttitham</creator><creator>Pongsuwan, Karn</creator><creator>Kusirisin, Prit</creator><creator>Wongsarikan, Nuttanun</creator><creator>Fanhchaksai, Kanda</creator><creator>Khamwan, Chantana</creator><creator>Dankai, Dararat</creator><creator>Ophascharoensuk, Vuddhidej</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7XB</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-3885-9377</orcidid><orcidid>https://orcid.org/0000-0002-1569-4581</orcidid></search><sort><creationdate>20230928</creationdate><title>Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175</title><author>Narongkiatikhun, Phoom ; Noppakun, Kajohnsak ; Chaiwarith, Romanee ; Winichakoon, Poramed ; Vongsanim, Surachet ; Suteeka, Yuttitham ; Pongsuwan, Karn ; Kusirisin, Prit ; Wongsarikan, Nuttanun ; Fanhchaksai, Kanda ; Khamwan, Chantana ; Dankai, Dararat ; Ophascharoensuk, Vuddhidej</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2668-49501a9ff89949b87c1a8af75178e50297c3013bd2454f09c6144018f5468fb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Immunogenicity</topic><topic>n/a</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Narongkiatikhun, Phoom</creatorcontrib><creatorcontrib>Noppakun, Kajohnsak</creatorcontrib><creatorcontrib>Chaiwarith, Romanee</creatorcontrib><creatorcontrib>Winichakoon, Poramed</creatorcontrib><creatorcontrib>Vongsanim, Surachet</creatorcontrib><creatorcontrib>Suteeka, Yuttitham</creatorcontrib><creatorcontrib>Pongsuwan, Karn</creatorcontrib><creatorcontrib>Kusirisin, Prit</creatorcontrib><creatorcontrib>Wongsarikan, Nuttanun</creatorcontrib><creatorcontrib>Fanhchaksai, Kanda</creatorcontrib><creatorcontrib>Khamwan, Chantana</creatorcontrib><creatorcontrib>Dankai, Dararat</creatorcontrib><creatorcontrib>Ophascharoensuk, Vuddhidej</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Vaccines (Basel)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Narongkiatikhun, Phoom</au><au>Noppakun, Kajohnsak</au><au>Chaiwarith, Romanee</au><au>Winichakoon, Poramed</au><au>Vongsanim, Surachet</au><au>Suteeka, Yuttitham</au><au>Pongsuwan, Karn</au><au>Kusirisin, Prit</au><au>Wongsarikan, Nuttanun</au><au>Fanhchaksai, Kanda</au><au>Khamwan, Chantana</au><au>Dankai, Dararat</au><au>Ophascharoensuk, Vuddhidej</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175</atitle><jtitle>Vaccines (Basel)</jtitle><date>2023-09-28</date><risdate>2023</risdate><volume>11</volume><issue>10</issue><spage>1538</spage><pages>1538-</pages><issn>2076-393X</issn><eissn>2076-393X</eissn><abstract>The authors wish to make the following correction to this paper [...]</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>37897029</pmid><doi>10.3390/vaccines11101538</doi><orcidid>https://orcid.org/0000-0002-3885-9377</orcidid><orcidid>https://orcid.org/0000-0002-1569-4581</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2076-393X
ispartof Vaccines (Basel), 2023-09, Vol.11 (10), p.1538
issn 2076-393X
2076-393X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_929c6cf426094921a033f21956622f43
source Open Access: PubMed Central; Publicly Available Content Database
subjects Immunogenicity
n/a
title Correction: Narongkiatikhun et al. Immunogenicity and Safety of Homologous and Heterologous Prime-Boost of CoronaVac® and ChAdOx1 nCoV-19 among Hemodialysis Patients: An Observational Prospective Cohort Study. Vaccines 2023, 11, 175
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A47%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Narongkiatikhun%20et%20al.%20Immunogenicity%20and%20Safety%20of%20Homologous%20and%20Heterologous%20Prime-Boost%20of%20CoronaVac%C2%AE%20and%20ChAdOx1%20nCoV-19%20among%20Hemodialysis%20Patients:%20An%20Observational%20Prospective%20Cohort%20Study.%20Vaccines%202023,%2011,%20175&rft.jtitle=Vaccines%20(Basel)&rft.au=Narongkiatikhun,%20Phoom&rft.date=2023-09-28&rft.volume=11&rft.issue=10&rft.spage=1538&rft.pages=1538-&rft.issn=2076-393X&rft.eissn=2076-393X&rft_id=info:doi/10.3390/vaccines11101538&rft_dat=%3Cproquest_doaj_%3E2883574811%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2668-49501a9ff89949b87c1a8af75178e50297c3013bd2454f09c6144018f5468fb73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2882848838&rft_id=info:pmid/37897029&rfr_iscdi=true